(+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo

Free Radical Biology and Medicine

Volumn 33, Issue 12, 2002, Pages 1670-1680

  Blache, Denis ^a,c   Durand, Philippe ^b   Prost, Michel ^b   Loreau, Nadine ^a  

^a INSERM   (France)

^b Ctr Europ de Rech et d'Analyses   (France)

^c Unit 498   (France)

Author keywords

Antioxidant; Catechin; Free radicals; Lipid oxidation; Oxidative stress; Platelet function

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CATECHIN; FREE RADICAL; IRON; POLYPHENOL;

ANIMAL CELL; ARTICLE; CACAO; CELL ACTIVITY; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HEMOLYSIS; IN VIVO STUDY; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TEA; THROMBOCYTE; THROMBOCYTE FUNCTION; WINE;

ANIMALS; BLOOD PLATELETS; CATECHIN; IRON; LIPID PEROXIDATION; MALE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; FELIS CATUS; THEOBROMA CACAO;

EID: 6444244426     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01139-5     Document Type: Article

References (65)

1. Steinberg D., Lewis A. Conner memorial lecture oxidative modification of LDL and atherogenesis . Circulation. 95:1997;1062-1071.
2. Parthasarathy S., Steinberg D. Cell-induced oxidation of LDL. Curr. Opin. Lipidol. 3:1992;313-317.
3. Penn M.S., Chisolm G.M. Oxidized lipoproteins, altered cell function, and atherosclerosis. Atherosclerosis. 108:(Suppl.):1994;S21-S29.
4. Blache D., Rodriguez C., Davignon J. Platelet-induced oxidative low-density lipoprotein modification. Atherosclerosis. 115:1995;S14.
5. Minotti G., Aust S.D. Redox cycling of iron and lipid peroxidation. Lipids. 27:1992;219-226.
6. De Valk B., Marx J.J.M. Iron, atherosclerosis, and ischemic heart disease. Archiv. Intern. Med. 159:1999;1542-1548.
7. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA. 94:1997;9866-9868.
8. White J.G. Platelets and atherosclerosis. Eur. J. Clin. Invest. 24:(Suppl. 1):1994;25-29.
9. Blache D. Involvement of hydrogen and lipid peroxides in the acute tobacco smoking-induced platelet hyperactivity. Am. J. Physiol. 268:1995;H679-H685.
10. Langford E.J., Wainwright R.J., Martin J.F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler. Thomb. Vasc. Biol. 16:1996;51-55.
11. Pignatelli P., Pulcinelli F.M., Lenti L., Gazzaniga P.P., Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood. 91:1998;484-490.
12. Iuliano L., Violi F., Pedersen J.Z., Pratic D., Rotilio G., Balsano F. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch. Biochem. Biophys. 299:1992;220-224.
13. Polette A., Blache D. Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake, and thromboxane biosynthesis in rat platelets. Atherosclerosis. 96:1992;171-179.
14. Barradas M.A., Jeremy J.Y., Kontoghioghes G.J., Mikhailidis D.P., Hoffbrand A.V., Dandona P. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis, and lipoxygenase activity. FEBS Lett. 245:1989;105-109.
15. Salonen J.T., Nyyssnen K., Korpela H., Tuomilehito J., Seppnen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
16. Jacob H.S. Newly recognized causes of atherosclerosis the role of microorganisms and of vascular iron overload . J. Lab. Clin. Med. 123:1994;808-816.
17. Magnusson M.K., Sigfusson N., Sigvaldason H., Johannesson G.M., Magnusson S., Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation. 89:1994;102-108.
18. Bravo L. Polyphenols chemistry, dietary sources, metabolism, and nutritional significance . Nutr. Rev. 56:1998;317-333.
19. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease the Zutphen elderly study . Lancet. 342:1993;1007-1011.
20. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1992;454-457.
21. Negre-Salvayre A., Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic. Biol. Med. 12:1991;101-106.
22. Beretz A., Cazenave J.P., Anton A. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids structure-activity relationship . Agents Actions. 12:1982;382-387.
23. Landolfi R., Mower R.L., Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids structure-activity relations . Biochem. Pharmacol. 33:1984;1525-1530.
24. Dreosti I.E. Antioxidant polyphenols in tea, cocoa, and wine. Nutrition. 16:2000;692-694.
25. St. Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1:1979;1017-1020.
26. Renaud S., De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
27. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid History, production, and role in disease prevention . J. Clin. Lab. Anal. 11:1997;287-313.
28. Durand P., Prost M., Blache D. Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity. Arterioscler. Thomb. Vasc. Biol. 17:1997;1939-1946.
29. Marcenac F., Blache D. Endogenous platelet serotonin release monitored during aggregation by means of a new electrochemical technique. Biochim. Biophys. Acta. 840:1985;377-382.
30. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90:1992;2502-2507.
31. Durand P., Blache D. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats. Atherosclerosis. 121:1996;205-216.
32. Prost, M. Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive agents. 1992. US Patent No. 576,460[5,135,850]. 4-8-1992.
33. Persijn J.P., Van Der Slik W., Riethorst A. Determination of serum iron and latent iron-binding capacity. Clin. Chim. Acta. 35:1971;91-99.
34. Das N.P. Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol. 20:1971;3435-3445.
35. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60:2000;1539-1548.
36. Gutteridge J.M.C., Halliwell B., Harrisson P., Treffy A., Blake D.R. Effect of ferritin containing fractions with different iron loading on lipid peroxidation. Biochem. J. 209:1983;557-560.
37. Lamb D.J., Leake D.S. Iron released from transferrin at acidic pH can catalyze the oxidation of low-density lipoprotein. FEBS Lett. 352:1994;15-18.
38. Drapper H.H., Polensek L., Hadley M., McGirr L.G. Effects of antioxidants on lipid peroxidation in iron-loaded rats. Lipids. 19:1984;836-843.
39. Dougherty J.J., Croft W.A., Hoekstra W.E. Effects of ferrous chloride and iron dextran on lipid peroxidation in vivo in vitamin E and selenium adequate and deficient rats. J. Nutr. 111:1981;1784-1796.
40. Galleano M., Puntarulo S. Dietary α-tocopherol supplementation on antioxidant defenses after in vivo iron overload in rats. Toxicology. 124:1997;73-81.
41. Iuliano L., Pedersen J.Z., Pratic D., Rotilio G., Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur. J. Biochem. 221:1994;695-704.
42. Pratic D., Iuliano L., Ghiselli A., Alessandri C., Violi F. Hydrogen peroxide as trigger of platelet aggregation. Haemostasis. 21:1991;169-174.
43. Pratic D., Pasin M., Barry O.P., Ghiselli A., Sabatino G., Iuliano L., FitzGerald G.A., Violi F. Iron-dependent human platelet activation and hydroxyl radical formation involvement of protein kinase C . Circulation. 99:1999;3118-3124.
44. Durand P., Prost M., Blache D. Prothrombotic effects of a folic acid-deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis. 121:1996;231-243.
45. Van Acker S.A.B.E., Van Balen G.P., Van den Berg D.J., Bast A., Van der Vijgh W.J.F. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem. Pharmacol. 56:1998;935-943.
46. Cao G.H., Sofic E., Prior R.L. Antioxidant and pro-oxidant behavior of flavonoids structure-activity relationships . Free Radic. Biol. Med. 22:1997;749-760.
47. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:1996;933-956.
48. Van Acker S.A.B.E., Van den Berg D.J., Tromp M.N.J.L., Griffioen D.H., Van Bennekom W.P., Van der Vijgh W.J.F., Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20:1996;331-342.
49. Hollman P.C.H., Van der Gaag M., Mengelers M.J.B., Van Trijp J.M.P., De Vries J.H., Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 21:1996;703-707.
50. Da Silva E.L., Piskula M., Terao J. Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radic. Biol. Med. 24:1998;1209-1216.
51. Nigdikar S.V., Williams N.R., Griffin B.A., Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am. J. Clin. Nutr. 68:1998;258-265.
52. Chopra M., Fitzsimons P.E., Strain J.J., Thurnham D.I., Howard A.N. Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. Clin. Chem. 46:2000;1162-1170.
53. Wan Y., Vinson J.A., Etherton T.D., Proch J., Lazarus S.A., Kris-Etherton P.M. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am. J. Clin. Nutr. 74:2001;596-602.
54. Conquer J.A., Maiani G., Azzini E., Raguzzini A., Holub B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 128:1998;593-597.
55. Janssen K., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., Katan M.B. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers results from an in vitro and a dietary supplement study . Am. J. Clin. Nutr. 67:1998;255-262.
56. Stoyanovsky D.A., Cederbaum A.I. Redox-cycling of iron ions triggers calcium release from liver microsomes. Free Radic. Biol. Med. 24:1998;745-753.
57. Mabile L., Meilhac O., Escargueil-Blanc I., Troly M., Pieraggi M.T., Salvayre R., Ngre-Salvayre A. Mitochondrial function is involved in LDL oxidation mediated by human cultured endothelial cells. Arterioscler. Thomb. Vasc. Biol. 17:1997;1575-1582.
58. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495:2001;12-15.
59. Wilcox J.N. Thrombotic mechanisms in atherosclerosis. Coron. Art. Dis. 5:1994;223-229.
60. Massaeli H., Pierce G.N. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc. Res. 29:1995;597-603.
61. Blache D., Bontoux G. Biological effects of oxysterols on platelet function. Thromb. Res. 50:1988;221-230.
62. Schroepfer G.J. Jr. Oxysterols modulators of cholesterol metabolism and other processes . Physiol. Rev. 80:2000;361-554.
63. Dabbagh A.J., Shwaery G.T., Keaney J.F. Jr., Frei B. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arterioscler. Thomb. Vasc. Biol. 17:1997;2638-2645.
64. Kirk E.A., Heinecke J.W., LeBoeuf R.C. Iron overload diminishes atherosclerosis in apoE-deficient mice. J. Clin. Invest. 107:2001;1545-1553.
65. Donovan J.L., Bell J.R., Kasim-Karakas S., German J.B., Walzem R.L., Hansen R.J., Waterhouse A.L. Catechin is present as metabolites in human plasma after consumption of red wine. J. Nutr. 129:1999;1662-1668.